bictegravir

1 January 2025. Related: ARVs, Integrase inhibitors.

no separate formulation

bik-teg-rah-vir

Bictegravir is a second-generation integrase inhibitor.

It is generally only available as part of the fixed dose combination called Biktarvy.

It is also being studied as part of a daily oral treatment with the capsid inhibitor lenacapavir.